Curcumin, hemostasis, thrombosis, and coagulation

被引:188
作者
Keihanian, Faeze [1 ,2 ]
Saeidinia, Amin [3 ]
Bagheri, Ramin Khameneh [2 ]
Johnston, Thomas P. [4 ]
Sahebkar, Amirhossein [5 ]
机构
[1] Mashhad Univ Med Sci, Div Pharmaceut Res, Booali Res Ctr, Mashhad, Iran
[2] Mashhad Univ Med Sci, Dept Cardiol, Fac Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Fac Med, Mashhad, Iran
[4] Univ Missouri Kansas City, Div Pharmaceut Sci, Sch Pharm, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Inst Pharmaceut Technol, Biotechnol Res Ctr, Mashhad, Iran
关键词
anticoagulant agent; antithrombotic agents; Curcumin; Curcuma longa; hemostasis; CELL-ADHESION MOLECULE-1; MICROVASCULAR ENDOTHELIAL-CELLS; RANDOMIZED CONTROLLED-TRIAL; PLATELET-ACTIVATING-FACTOR; SYSTEMIC OXIDATIVE STRESS; FIBRINOGEN-LIKE PROTEIN-2; FATTY LIVER-DISEASE; I CLINICAL-TRIAL; PIPERINE COMBINATION; TNF-ALPHA;
D O I
10.1002/jcp.26249
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Atherothrombotic cardiovascular disease is a major cause of mortality throughout the world. Platelet activation and aggregation play a central role in hemostasis and thrombosis. Herbal medicines have been traditionally used in the management of cardiovascular disease and can help in modifying its progression, particularly in hemostasis and the coagulation process, as well as altering platelet function tests and some coagulation parameters. Curcumin is a polyphenol derived from the Curcuma longa plant and has been used extensively in complementary and alternative medicine, as it is nontoxic and safe with various therapeutic properties. Modern scientific research has demonstrated its anti-inflammatory, antioxidant, anti-carcinogenic, antithrombotic, and cardiovascular protective effects. The present study reviewed previous studies in the literature, which support the positive activity of curcumin in hemostasis, anticoagulation, and fibrinolysis. We also presented molecular mechanisms associated with the antiplatelet and anticoagulant activities of curcumin and potential implications for the treatment of cardiovascular disease.
引用
收藏
页码:4497 / 4511
页数:15
相关论文
共 136 条
[1]
Abdollahi E., 2017, J CELLULAR IN PRESS
[2]
Synthesis and characterization of curcumin segmented polyurethane with induced antiplatelet activity [J].
Abdollahi, Maryam Faghih ;
Zandi, Mojgan ;
Shokrollahi, Parvin ;
Ehsani, Morteza .
JOURNAL OF POLYMER RESEARCH, 2015, 22 (09)
[3]
Review article: Coagulation cascade and therapeutics update: Relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants [J].
Adams, Rebecca L. C. ;
Bird, Robert J. .
NEPHROLOGY, 2009, 14 (05) :462-470
[4]
REGULATION OF ARACHIDONATE-INDUCED PLATELET-AGGREGATION BY THE LIPOXYGENASE PRODUCT, 12-HYDROPEROXYEICOSATETRAENOIC ACID [J].
AHARONY, D ;
SMITH, JB ;
SILVER, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 718 (02) :193-200
[5]
Curcumin inhibits in vitro MCP-1 release from mouse pancreatic islets [J].
Amoli, M. M. ;
Mousavizadeh, R. ;
Sorouri, R. ;
Rahmani, M. ;
Larijani, B. .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (09) :3035-3038
[6]
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature [J].
Anand, Preetha ;
Thomas, Sherin G. ;
Kunnumakkara, Ajaikumar B. ;
Sundaram, Chitra ;
Harikumar, Kuzhuvelil B. ;
Sung, Bokyung ;
Tharakan, Sheeja T. ;
Misra, Krishna ;
Priyadarsini, Indira K. ;
Rajasekharan, Kallikat N. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1590-1611
[7]
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[8]
Banno Y, 1998, THROMB HAEMOSTASIS, V79, P1008
[9]
In vitro mutagenicity and blood compatibility of paclitaxel and curcumin in poly (DL-lactide-co-glicolide) films [J].
Barbosa Fernandes Vieira, Iara Lucia ;
Passos de Souza, Debora Cristina ;
Coelho, Liliane da Silva ;
Chen, Lee Chen ;
Guillo, Lidia Andreu .
TOXICOLOGY IN VITRO, 2013, 27 (01) :198-203
[10]
Future innovations in anti-platelet therapies [J].
Barrett, N. E. ;
Holbrook, L. ;
Jones, S. ;
Kaiser, W. J. ;
Moraes, L. A. ;
Rana, R. ;
Sage, T. ;
Stanley, R. G. ;
Tucker, K. L. ;
Wright, B. ;
Gibbins, J. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (05) :918-939